Product Name: Etofibrate CAS NO:31637-97-5
ethylene glycol 1-[2-(p-chlorophenoxy)-2-methylpropionate]-2-nicotinate;
Chemical & Physical Properties:
Appearance :white to off-white powder
Boiling Point: 486.8℃ at 760 mmHg
Melting Point: 42-44℃
Etofibrate (English Etofibrate) trade name is Lipo-Merz, which is a broad-spectrum and high-efficiency new drug for regulating blood lipids. Etofibrate is a compound of antuomin and niacin. After taking it, it is decomposed into antuomin and niacin in the body to produce a rapid and long-lasting effect. It is characterized by inhibiting the synthesis of cholesterol and triglycerides and increasing the excretion of sterol feces. It is mainly used clinically to reduce plasma triglycerides. For the treatment of hyperlipidemia (severe primary and secondary hyperlipidemia), atherosclerosis, cerebrovascular and terminal vascular disorders, vascular and retinal vascular disease, prevention of stroke, heart disease, myocardial infarction, hyperlipidemia Blood pressure, hyperlipidemia, obesity, blood circulation disorders, etc. Etofibrate is a phenoxyacetic acid and niacin lipid-regulating drug developed by the German Merz company. It is suitable for hyperlipidemia. It has been marketed in Germany, France, and Italy, but has not yet been marketed in China.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.